ERBB2 and carcinoma: From a mammary carcinoma spontaneously developed in HER-2/neu transgenic mice, we previously established a carcinoma derived mesenchymal tumor cell lineage, called A17 [18], capable of developing highly aggressive mesenchymal tumors when injected into syngeneic mice.